Furthermore, the study also extended its investigation to animal models by xenografting lung cancer cells that expressed the EGFR T790M mutation, providing additional evidence supporting the potential efficacy of UA in treating this specific subtype of NSCLC [16]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.